- Home
- PLTK vs ATAI Comparison
PLTK vs ATAI Comparison
Compare PLTK & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLTK | ATAI |
|---|---|---|
| Founded | 2010 | 2018 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2020 | 2025 |
Fundamental Metrics
Financial Performance| Metric | PLTK | ATAI |
|---|---|---|
| Price | $3.42 | $4.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | $5.04 | ★ $15.88 |
| AVG Volume (30 Days) | 1.6M | ★ 5.0M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | ★ 11.46% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,755,400,000.00 | $4,089,000.00 |
| Revenue This Year | $2.60 | N/A |
| Revenue Next Year | $2.23 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 8.08 | ★ 1227.60 |
| 52 Week Low | $2.64 | $2.00 |
| 52 Week High | $5.05 | $6.73 |
Technical Indicators
Market Signals| Indicator | PLTK | ATAI |
|---|---|---|
| Relative Strength Index (RSI) | 56.06 | 48.20 |
| Support Level | $3.35 | $4.00 |
| Resistance Level | $3.80 | $4.20 |
| Average True Range (ATR) | 0.20 | 0.33 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 61.84 | 29.20 |
Price Performance
Historical ComparisonAbout PLTK Playtika Holding Corp.
Playtika Holding Corp is engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC, and Other regions of which key revenue is derived from the USA. The company offers both Mobile and Web-based platforms.
About ATAI ATAI Life Sciences N.V.
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.